Log in to save to my catalogue

On‐Site Quantification and Infection Risk Assessment of Airborne SARS‐CoV‐2 Virus Via a Nanoplasmoni...

On‐Site Quantification and Infection Risk Assessment of Airborne SARS‐CoV‐2 Virus Via a Nanoplasmoni...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ecdd832401314897a73f9ee40a7dd17f

On‐Site Quantification and Infection Risk Assessment of Airborne SARS‐CoV‐2 Virus Via a Nanoplasmonic Bioaerosol Sensing System in Healthcare Settings

About this item

Full title

On‐Site Quantification and Infection Risk Assessment of Airborne SARS‐CoV‐2 Virus Via a Nanoplasmonic Bioaerosol Sensing System in Healthcare Settings

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Advanced science, 2022-12, Vol.9 (35), p.e2204774-n/a

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

On‐site quantification and early‐stage infection risk assessment of airborne severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with high spatiotemporal resolution is a promising approach for mitigating the spread of coronavirus disease 2019 (COVID‐19) pandemic and informing life‐saving decisions. Here, a condensation (hygroscopic growth)...

Alternative Titles

Full title

On‐Site Quantification and Infection Risk Assessment of Airborne SARS‐CoV‐2 Virus Via a Nanoplasmonic Bioaerosol Sensing System in Healthcare Settings

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ecdd832401314897a73f9ee40a7dd17f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ecdd832401314897a73f9ee40a7dd17f

Other Identifiers

ISSN

2198-3844

E-ISSN

2198-3844

DOI

10.1002/advs.202204774

How to access this item